NCT04532216

Brief Summary

Acromioclavicular joint dislocation is a common disease in shoulder surgery, which mostly occurs in young and middle-aged patients. Severe acromioclavicular joint dislocations of Rockwood type IV, V, and VI require surgical treatment. Among them, the common clinical type IV and type V severe acromioclavicular joint dislocations are often treated with autologous/allogenous tendon transplantation and coracoclavicular ligament reconstruction under shoulder arthroscopy. Although this minimally invasive surgical method has certain advantages over incision surgery, due to factors such as poor healing after tendon transplantation and failure of coracoclavicular fixation, the recurrence rate of postoperative dislocation is still as high as 30%, which seriously affects the prognosis of patients. Therefore, we proposed a new surgical technique of minimally invasive shoulder arthroscopic coracoclavicular suspension fixation and coracoclavicular ligament residual reconstruction, which aims to strengthen the fixation strength of the coracoclavicular space, promote the healing of the coracoclavicular ligament, and reduce the recurrence rate of postoperative dislocation. To improve postoperative shoulder joint function of patients. This project intends to use non-randomized controlled clinical research and biomechanical research to compare traditional surgical techniques with new microscopic techniques in terms of surgical efficacy, postoperative complications, and internal plant fixation strength to establish the therapeutic advantages of the new technology. Its application and promotion provide important clinical evidence to improve the treatment of severe acromioclavicular joint dislocation in the field of shoulder surgery.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2020

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 26, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 31, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

September 1, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

August 31, 2020

Status Verified

August 1, 2020

Enrollment Period

1.8 years

First QC Date

August 26, 2020

Last Update Submit

August 26, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • ASES score

    The ASES score is a 10-item measure of shoulder pain and function

    1 year postoperatively

Study Arms (2)

Study group

EXPERIMENTAL
Procedure: Arthroscopic-Assisted Acromioclavicular Joint Reconstruction Using the TightRope Device

Control group

OTHER
Procedure: Traditional surgery

Interventions

Arthroscopic-assisted AC joint reconstruction with the TightRope device with allograft augmentation and with the patient in the lateral decubitus position is a method of restoring joint stability

Study group

Tendon transfer

Control group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Consecutive cases of coracoclavicular ligament reconstruction surgery usingTightRope Device With Allograft Augmentation and shoulder arthroscopic reconstruction of coracoclavicular ligament with autologous/allogeneic tendon transplantation.
  • Injury type Rockwood type IV and V type severe acromioclavicular joint dislocation
  • The time from injury to operation is less than 3 weeks

You may not qualify if:

  • Combined with neurovascular injury
  • Previous history of ipsilateral shoulder surgery
  • The patient refused to sign the informed consent and participate in the trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Chunyan Jiang

    Sports Medicine Service, Beijing Jishuitan hospital

    STUDY CHAIR

Central Study Contacts

Zhijun Zhang, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Sports Medicine Service of Beijing Jishuitan hospital

Study Record Dates

First Submitted

August 26, 2020

First Posted

August 31, 2020

Study Start

September 1, 2020

Primary Completion

June 30, 2022

Study Completion

June 30, 2023

Last Updated

August 31, 2020

Record last verified: 2020-08